Free practice quiz
BCNSP Prep Course (BCNSP): free quiz
10 questions from the program. See your score right away, then unlock the explanation of every answer.
- Question 1 of 10
A PN order for dextrose 250 g, amino acids 90 g, and potassium phosphate 40 mmol IV over 24 hours is entered for a postoperative adult with a newly placed PICC. During pharmacist verification, the latest potassium is 6.1 mEq/L and the hemolysis comment is absent. What is the most appropriate pharmacist action?
Correct answer: Hold and clarify
Hyperkalemia is a major safety signal. A pharmacist should prevent dispensing a PN formula containing potassium until the result is clarified and the prescriber is contacted. This aligns with pharmacist responsibility for verification, monitoring, and escalation rather than independent prescribing.
NOTICE: potassium-containing PN with potassium 6.1 mEq/L. SAY: recommend immediate order clarification and discuss potassium-free alternatives if appropriate. MONITOR: repeat potassium and ECG/clinical status per team urgency. HOLD/CLARIFY/ESCALATE: hold release until discrepancy is resolved.
Why the other options are incorrect
A: Tempting because it reduces potassium exposure, but independently changing the prescribed formula exceeds scope unless authorized by policy or prescriber. C: Continuous infusion does not mitigate unsafe potassium exposure. D: Assessing/using the line in that manner is not the pharmacist's role in this stem; the problem is order safety, not line function.
- Question 2 of 10
A pharmacist is checking a home PN prescription containing amino acids 75 g/day, dextrose 240 g/day, multivitamins 10 mL/day, and trace elements 1 mL/day IV cyclic over 12 hours. The order omits the final total volume. What is the safest next step?
Why A is correct
Final volume is essential to verify concentrations, osmolarity, infusion rate, and compounding accuracy. Missing final volume is an unresolved order defect, so the pharmacist should clarify before preparation. This is a straightforward verification checkpoint in the exam framework.
NOTICE: PN volume missing from the order. SAY: volume is required to confirm concentration and administration rate. MONITOR: revised order completeness before compounding. HOLD/CLARIFY/ESCALATE: hold any incomplete PN order with calculation-critical omissions.
Why the other options are incorrect
D: Tempting because 2 L is common, but assumptions can create unsafe concentrations. C: Prior PN may not reflect current needs. B: Vitamin volume has no role in assigning total PN volume.
NOTICE: incomplete prescription elements. SAY: request the missing final volume. MONITOR: workflow for incomplete discharge PN orders. HOLD/CLARIFY/ESCALATE: escalate recurrent omissions that threaten timely safe discharge.
- Question 3 of 10
The pharmacist checks a PN order written as sodium acetate 30 mEq/day IV and potassium acetate 20 mEq/day IV in the same final bag. What is the combined acetate salt amount from these two additives in mEq per day?
Why D is correct
The pharmacist adds the two daily electrolyte amounts directly: 30 mEq/day plus 20 mEq/day equals 50 mEq/day combined. The key is that both values are already expressed in the same unit and same time frame.
Pharmacist Action: NOTICE whether electrolyte values share the same unit and interval before adding them. SAY the summed total only after confirming both are daily amounts. MONITOR acid-base-related electrolyte totals each formulation cycle. HOLD/CLARIFY/ESCALATE if one source is listed per liter and the other per day.
Why the other options are incorrect
A: Tempting if one value is doubled accidentally. C: Tempting if only sodium acetate is counted. B: Tempting if only potassium acetate is counted. The eliminating fact for all three is that both daily amounts must be included once.
- Question 4 of 10
A pharmacist reviews chronic medication and nutrition therapy for a patient taking colesevelam 625 mg, 3 tablets by mouth twice daily, and an oral supplement providing 15 g fat per serving twice daily. Which absorption consequence is most expected from bile acid sequestration?
Why B is correct
Bile acid sequestrants bind bile acids in the lumen, reducing micelle formation and impairing absorption of long-chain fats and fat-soluble vitamins. For pharmacists, this interaction matters when evaluating oral supplements, EN tolerance, and medication timing.
NOTICE bile acid sequestrant use with oral nutrition products. SAY fat-soluble vitamin absorption may decline. MONITOR stool changes and vitamin status if prolonged therapy. CLARIFY timing separation and supplementation needs.
Why A is incorrect
Tempting because bile acids and fat absorption are linked. The eliminating fact is that sequestration decreases rather than improves micelle formation.
NOTICE direction of effect. SAY bile acid binding impairs, not enhances, lipid uptake. MONITOR tolerance and deficiency risk. HOLD misleading counseling.
Why C is incorrect
Tempting because nutrient transport often uses cotransporters. The eliminating fact is that glucose absorption via SGLT1 does not require bile acids.
NOTICE unrelated transport mechanism. SAY expected issue is fat-related, not glucose-specific. MONITOR glucose separately based on formula and disease state. CLARIFY mechanism with the team.
Why D is incorrect
Tempting because the terminal ileum handles both bile acids and B12. The eliminating fact is that bile acid sequestration does not improve intrinsic factor-mediated B12 absorption.
NOTICE shared site does not imply enhanced B12 uptake. SAY ileal physiology differs by nutrient. MONITOR B12 only if other risk factors exist. ESCALATE persistent deficiency concerns appropriately.
- Question 5 of 10
A pharmacist reviews a protein goal for an adult with open fractures receiving PN with amino acids 85 g/day IV continuously, dextrose 190 g/day, and lipid 40 g/day. Serum creatinine is stable, and urine output is adequate. Which statement best reflects the effect of critical illness on protein metabolism?
Correct answer: Critical illness raises protein turnover and breakdown
Trauma and inflammation commonly increase protein turnover and net proteolysis. Pharmacists should recognize that standard maintenance protein doses may underdeliver support in such patients, even when renal function is stable enough to tolerate higher provision.
Pharmacist Action: NOTICE active trauma with only moderate amino acid provision; SAY protein needs may exceed unstressed requirements; MONITOR renal function, urea trends, and delivered protein daily; HOLD/CLARIFY/ESCALATE if the prescribed protein seems low for injury severity.
Why the other options are incorrect
A: Tempting because tissue breakdown releases amino acids, but that does not mean requirements fall. C: Tempting because renal stability influences dosing comfort, yet stress still affects protein metabolism. D: Tempting due to protein-sparing concepts, but dextrose alone does not determine catabolism.
Pharmacist Action: NOTICE confusion between tolerance and need; SAY stable kidneys do not erase stress catabolism; MONITOR adequacy and biochemical response; HOLD/CLARIFY/ESCALATE if maintenance thinking persists in a hypercatabolic state.
- Question 6 of 10
A pharmacist verifies potassium phosphate 15 mmol IV once in 250 mL and reviews a patient whose serum sodium increased after inadequate tube-water flushes. Which additional finding would best support a free-water deficit rather than sodium-rich extracellular loss?
Why C is correct
High-fever insensible losses disproportionately remove water, favoring a free-water deficit and possible hypernatremia. In contrast, ileostomy output, gastric suction, and loop diuresis often involve more sodium-rich extracellular losses. Pharmacist interpretation should distinguish these patterns before recommending replacement strategies.
Pharmacist Action: NOTICE fever and poor free-water intake/flushes; SAY the pattern supports water deficit rather than primarily isotonic GI loss; MONITOR sodium trend, urine output, and ongoing losses; HOLD/CLARIFY sodium-rich replacement alone if hypernatremia appears driven by water deficit.
Why A is incorrect
This is tempting because any output causes dehydration. The eliminating fact is that ileostomy losses are typically extracellular and sodium rich.
Why B is incorrect
This may appeal because suction can raise sodium indirectly. The eliminating fact is that gastric suction is a classic extracellular chloride- and sodium-containing loss, not isolated free-water depletion.
Why D is incorrect
This is tempting because diuretics can raise sodium if water intake is low. The eliminating fact is that loop diuretics commonly produce natriuresis and extracellular contraction, making this less supportive of isolated free-water deficit.
- Question 7 of 10
A pharmacist reviews an adult home PN formula containing sodium chloride 120 mEq IV daily, potassium chloride 50 mEq IV daily, and no free-water adjustment. The patient reports high ostomy output. Labs show sodium 150 mEq/L, potassium 3.3 mEq/L, magnesium 1.7 mg/dL, bicarbonate 19 mEq/L, serum creatinine 1.0 mg/dL. Which interpretation best fits the pattern?
Why B is correct
High intestinal output can produce significant water, sodium, potassium, and bicarbonate losses. If water replacement is inadequate, hypernatremia may develop despite ongoing sodium losses. The low bicarbonate supports intestinal bicarbonate loss rather than gastric alkalosis.
Pharmacist Action: NOTICE hypernatremia plus hypokalemia and low bicarbonate in the setting of high ostomy output; SAY that output-driven water and electrolyte losses likely require regimen adjustment beyond sodium concentration alone; MONITOR output volume and daily electrolytes; HOLD/CLARIFY/ESCALATE if dehydration or worsening hypernatremia persists.
Why the other options are incorrect
A: Tempting because PN sodium content matters, but free-water deficit from output can be a major driver. D: Tempting if GI losses are generalized, but intestinal losses are more associated with acidosis, not alkalosis. C: Tempting because salt forms affect acid-base balance, yet chloride salts do not inherently lower potassium independent of losses.
- Question 8 of 10
A pharmacist assesses lipid dosing in a 900-g premature infant receiving amino acids 3 g/kg/day, dextrose 8 mg/kg/min, and intravenous lipid emulsion 3 g/kg/day. Which monitoring priority is most age-specific?
Why D is correct
Premature infants, especially very low birth weight infants, may have reduced lipid clearance. Early triglyceride monitoring helps pharmacists verify tolerance and prevent excess exposure while still supporting growth and essential fatty acid provision.
NOTICE: Prematurity with relatively high lipid exposure per kg. SAY: Recommend early triglyceride monitoring after initiation or dose changes. MONITOR: Triglycerides and signs of intolerance per neonatal protocol. HOLD/CLARIFY/ESCALATE: Clarify or reduce dosing if triglycerides are persistently elevated or tolerance is poor.
Why the others are incorrect
A: Tempting because coagulation may be checked in critical illness, but INR is not the primary short-term lipid tolerance marker. B: Tempting because albumin reflects nutrition broadly, yet it is a poor short-term tolerance marker. C: Tempting because the dose is within a common range, but monitoring is still needed in premature infants. The discriminating fact is immature lipid clearance.
- Question 9 of 10
A pharmacist reviews a PN trace element order for a 62-year-old adult with bilirubin elevation and persistent cholestasis. The order continues standard multi-trace elements plus copper 2 mg IV daily from a separate additive. Which toxicity concern is most appropriate to raise during verification?
Why D is correct
Copper is largely excreted in bile, so cholestasis increases the risk of accumulation. Duplicate or high supplemental copper during biliary dysfunction should prompt pharmacist clarification and individualized trace element reassessment.
Pharmacist Action: NOTICE cholestasis plus added copper beyond standard trace elements; SAY copper accumulation risk is increased; MONITOR liver markers and total trace element exposure at each reassessment; HOLD/CLARIFY/ESCALATE if copper is continued without considering impaired biliary excretion.
Why the other options are incorrect
A: Chromium handling does not make it the primary cholestasis-related toxicity concern here. B: Zinc is mainly not limited by biliary excretion in the same way, and acute neurologic toxicity is not typical. C: Thiamine accumulation is not a standard concern in cholestasis.
Pharmacist Action: NOTICE organ dysfunction as a trigger to individualize trace elements; SAY why separate additives increase risk of oversupply; MONITOR whether cholestasis persists over time; HOLD/CLARIFY/ESCALATE if multiple copper-containing products are present.
- Question 10 of 10
A pharmacist is verifying a nutrition plan for a 52-year-old adult with Promote with Fiber 75 mL/hour via gastrostomy tube. Medication profile includes prednisone 40 mg by mouth daily and trimethoprim-sulfamethoxazole DS 1 tablet by mouth three times weekly. Which assessment element is most important to review because it can substantially affect interpretation of current weight and body composition?
Why D is correct
Anthropometrics require context in patients with amputations because measured weight and derived indices may not reflect standard body composition assumptions. The pharmacist should identify amputation status before relying on routine weight-based estimates for nutrition support design or verification.
NOTICE: possible altered anthropometric baseline. SAY: standard weight interpretation may need adjustment in amputation. MONITOR: documented adjusted weight method and adequacy. HOLD/CLARIFY/ESCALATE: clarify dosing weight if limb loss is present and not accounted for.
Why A is incorrect
This is tempting because administration preferences can matter for tolerance, but the eliminating fact is that preference does not change anthropometric interpretation. Amputation status does.
NOTICE: comfort preference vs dosing variable. SAY: anthropometric validity depends on body composition context. MONITOR: actual delivery and tolerance separately. HOLD/CLARIFY/ESCALATE: keep weight method accurate.
Why C is incorrect
This is tempting because fiber may affect GI tolerance, but the single eliminating fact is that fiber content does not alter the mathematical meaning of body weight. Amputation does.
NOTICE: formula characteristic unrelated to weight interpretation. SAY: dosing weight requires clinical context. MONITOR: bowel tolerance independently. HOLD/CLARIFY/ESCALATE: clarify anthropometric assumptions.
Why B is incorrect
This is tempting because steroid timing can matter for administration, but it does not establish a correction for body composition estimation. The key fact is that amputation materially changes anthropometric interpretation.
NOTICE: medication timing is not the key anthropometric issue. SAY: confirm body composition context. MONITOR: documented weight basis. HOLD/CLARIFY/ESCALATE: request clarification if needed.
See why each answer is right or wrong
Enter your email to unlock the explanation of every question, free.


